These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9423936)

  • 21. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
    Helsley S; Fiorella D; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):419-25. PubMed ID: 9476990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al.
    Romano AG; Quinn JL; Li L; Dave KD; Schindler EA; Aloyo VJ; Harvey JA
    Psychopharmacology (Berl); 2010 Oct; 212(3):441-8. PubMed ID: 20827462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
    Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
    Smith RL; Canton H; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
    Krebs KM; Geyer MA
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioural and autoradiographic study.
    Moorman JM; Leslie RA
    Neuropharmacology; 1998; 37(3):357-74. PubMed ID: 9681934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.
    Batman AM; Munzar P; Beardsley PM
    Psychopharmacology (Berl); 2005 May; 179(2):393-401. PubMed ID: 15565434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus.
    Jha S; Rajendran R; Fernandes KA; Vaidya VA
    Neurosci Lett; 2008 Aug; 441(2):210-4. PubMed ID: 18603367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.
    Marona-Lewicka D; Nichols DE
    Pharmacol Biochem Behav; 2007 Oct; 87(4):453-61. PubMed ID: 17618679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats.
    Trulson ME
    Pharmacol Biochem Behav; 1986 Feb; 24(2):351-7. PubMed ID: 3952126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation.
    Dave KD; Harvey JA; Aloyo VJ
    Pharmacol Biochem Behav; 2002 May; 72(1-2):371-8. PubMed ID: 11900808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.
    Body S; Cheung TH; Bezzina G; Asgari K; Fone KC; Glennon JC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2006 Dec; 189(3):331-43. PubMed ID: 17051415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
    Egan CT; Herrick-Davis K; Miller K; Glennon RA; Teitler M
    Psychopharmacology (Berl); 1998 Apr; 136(4):409-14. PubMed ID: 9600588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.